Terms, privacy and investor notices

Legal

Terms of Use

Effective October 31, 2026 · KronosMD, Inc.

These Terms of Use govern your access to and use of www.kronosmd.com and any subdomains (the “Site”), operated by KronosMD, Inc. (“KronosMD”, “we”, “us”). By using the Site you agree to these Terms. If you do not agree, do not use the Site.

1. Informational purpose

The Site describes KronosMD’s technology, research and business. It is provided for general information only. Nothing on the Site is medical, dental, legal, tax or investment advice, and nothing on the Site creates a doctor–patient or adviser–client relationship.

2. Products in development

S-WAVE™ is an investigational device. It has not been tested in people and is not cleared or approved by the U.S. Food and Drug Administration or any other regulator. Descriptions of what the product is “designed to” do describe design intent, not demonstrated performance. The product is not available for sale.

3. Securities

The Site is not an offer to sell or a solicitation of an offer to buy any security. Any offering of KronosMD securities is made only through the offering materials filed with the SEC and hosted on the funding portal identified on our Investors page, and is subject to the Investor Notices.

4. Intellectual property

The Site, its design, text, images, illustrations, data visualizations and software are owned by KronosMD or its licensors and protected by copyright, trademark and other laws. You may view, download and print pages for personal, non-commercial use, provided you keep all proprietary notices. Any other use, including republication or framing, requires our written permission. S-WAVE™ and the KronosMD name and logo are trademarks of KronosMD, Inc. See Trademarks.

5. Acceptable use

You agree not to: use the Site in any way that violates applicable law; attempt to gain unauthorized access to any part of the Site or its systems; scrape, harvest or mine data from the Site by automated means without permission; introduce malware or interfere with the Site’s operation; impersonate any person or misrepresent your affiliation; or use any content to make claims about S-WAVE™ that the Site does not make. See the Website Usage Policy.

6. Third-party links and content

The Site links to third-party sites, including the funding portal, the SEC’s EDGAR system, journals and regulators. We do not control and are not responsible for their content, policies or availability. Peer-reviewed studies are summarized from published abstracts; the summaries are ours and the original publications govern.

7. Disclaimer of warranties

THE SITE IS PROVIDED “AS IS” AND “AS AVAILABLE” WITHOUT WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ACCURACY OR UNINTERRUPTED AVAILABILITY. Content may contain errors or become outdated; we may change it at any time without notice.

8. Limitation of liability

TO THE FULLEST EXTENT PERMITTED BY LAW, KRONOSMD AND ITS OFFICERS, DIRECTORS, EMPLOYEES, ADVISERS AND AGENTS SHALL NOT BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, OR ANY LOSS OF PROFITS, DATA OR GOODWILL, ARISING FROM YOUR USE OF OR INABILITY TO USE THE SITE, EVEN IF ADVISED OF THE POSSIBILITY. OUR TOTAL LIABILITY FOR ANY CLAIM RELATING TO THE SITE SHALL NOT EXCEED ONE HUNDRED U.S. DOLLARS ($100). Some jurisdictions do not allow these limitations, so they may not apply to you.

9. Indemnity

You agree to indemnify and hold harmless KronosMD from claims, losses and expenses (including reasonable attorneys’ fees) arising from your breach of these Terms or misuse of the Site.

10. Governing law and disputes

These Terms are governed by the laws of the State of California, without regard to conflict-of-law rules. Any dispute shall be brought exclusively in the state or federal courts located in Ventura County, California, and you consent to their jurisdiction. Nothing in this section limits rights investors have under federal securities laws.

11. Changes

We may revise these Terms by posting an updated version with a new effective date. Continued use after a change means you accept the revised Terms.

12. Contact

Questions about these Terms: Contact · [email protected].

Legal

Privacy Policy

Effective October 31, 2026 · KronosMD, Inc.

This Privacy Policy explains what information KronosMD collects through the Site, how we use it, and the choices you have. It is written to meet the California Consumer Privacy Act (CCPA/CPRA), CalOPPA and, for visitors outside the United States, the general principles of the GDPR and UK GDPR.

Information we collect

• Information you give us: name, email address, phone number and message content when you contact us, request updates or ask investor questions.
• Information collected automatically: IP address, browser and device type, pages viewed, referring page, and timestamps, collected through server logs and, if you consent, analytics cookies. See the Cookie Policy.
• Investment information is collected by the funding portal, not by this Site. The portal’s privacy policy governs it. We receive from the portal only the information needed to maintain our shareholder records and communicate with investors.

We do not collect health information through the Site, and we ask that you do not send us dental or medical records. S-WAVE™ is not available and no patient data is collected.

How we use information

• To respond to your enquiries and send updates you asked for.
• To maintain shareholder records and meet securities-law obligations, including ongoing reporting.
• To operate, secure and improve the Site and understand how it is used.
• To comply with law, enforce our Terms and protect rights and safety.

Legal bases (EEA/UK visitors)

Performance of a contract or steps at your request; our legitimate interests in operating the Site and communicating with investors; your consent for non-essential cookies and marketing emails; and compliance with legal obligations.

Sharing

We share information with service providers that host the Site, send email and provide analytics, under contracts that restrict their use of it; with the funding portal, transfer agent, escrow agent, auditors and counsel as needed for the offering and shareholder administration; with regulators where required by law; and in a merger, financing or sale of assets, subject to this Policy. We do not sell personal information and do not share it for cross-context behavioral advertising.

Retention

Enquiries are kept for up to three years after the last contact. Shareholder records are kept for as long as you hold our securities and for the period required by law afterwards. Server logs are kept for up to 12 months.

Your rights

Depending on where you live you may have the right to know what personal information we hold, to access, correct or delete it, to opt out of sale or sharing (we do none), to limit use of sensitive information (we collect none), to data portability, and not to be discriminated against for exercising these rights. EEA/UK visitors may also object to or restrict processing and complain to a supervisory authority. To exercise any right email [email protected] with “Privacy request” in the subject; we will verify your identity and respond within 45 days (CCPA) or one month (GDPR). You may use an authorized agent as permitted by law.

Do Not Track and Global Privacy Control

We honor Global Privacy Control signals as an opt-out of any sale or sharing. Because we do none, no change in treatment results.

Children

The Site is not directed to children under 16 and we do not knowingly collect their information. If you believe a child has provided information, contact us and we will delete it.

Security and international transfers

We use reasonable administrative, technical and physical safeguards. Information is processed in the United States; by using the Site from elsewhere you understand it will be transferred there.

Changes and contact

We will post any changes here with a new effective date. Contact: KronosMD, Inc., 1000 Newbury Rd., Suite 290A, Thousand Oaks, CA 91320 · [email protected].

Legal

Cookie Policy

Effective October 31, 2026 · KronosMD, Inc.

Cookies are small files stored by your browser. The Site uses as few as possible.

Cookies we use

Your choices

Use the banner to accept or decline analytics cookies; change your choice at any time with the “Cookie settings” link in the footer. You can also block or delete cookies in your browser; strictly necessary features may then not work. Declining does not affect your ability to read the Site or to invest through the funding portal.

Legal

Accessibility Statement

Effective October 31, 2026 · KronosMD, Inc.

KronosMD wants everyone to be able to read about dental ultrasound. We aim to conform to the Web Content Accessibility Guidelines (WCAG) 2.2, Level AA.

What we have done

• Semantic headings, landmarks and a logical reading order on every page.
• Text alternatives on images and illustrations; data visualizations are accompanied by the underlying figures in text.
• Keyboard access to all interactive elements, including the image comparison slider (a native range control) and the applications map.
• Color contrast of at least 4.5:1 for body text, and information never conveyed by color alone.
• Responsive layout that works at 400% zoom and on phones; animations respect the “reduce motion” setting.

Known limitations

Some embedded third-party content (videos, the funding portal) is outside our control. Captions are provided on our own videos; a transcript is available on request.

Feedback

If you have difficulty using any part of the Site, email [email protected] or call +1 (812) 792-8387. We aim to respond within five business days and to provide the information in an alternative format.

Legal

Medical and Product Disclaimer

Effective October 31, 2026 · KronosMD, Inc.

Not medical advice

Content on this Site is for general information and education. It is not a substitute for professional dental or medical advice, diagnosis or treatment. Always consult a licensed dentist or physician about any oral-health question, and never delay seeking care because of something you read here.

Investigational device

S-WAVE™ is in development. It has not been tested in people, is not cleared or approved by the FDA or any other regulator, and is not available for purchase. Statements describing what S-WAVE™ is “designed to” do describe design intent. Performance in people has not been established and may differ from laboratory results. Images labelled “raw” or “bench” were produced by a laboratory bench prototype, not by the consumer device, which has not been built. Product images are concept renderings; the final product may differ.

Imaging and monitoring only

The intended use KronosMD is pursuing is imaging and monitoring with review by a licensed dentist. S-WAVE™ is not intended to diagnose, treat, cure or prevent any disease, and the Site makes no such claim. Items marked “future research” are not part of the current product and would require their own regulatory authorization.

Published research

Studies cited on the Site were conducted by independent researchers using research-grade ultrasound systems, not S-WAVE™. Our summaries are drawn from published abstracts; the original publications govern. Results in a study do not predict S-WAVE™’s performance.

Radiation comparisons

Dental X-rays are low-dose and, used appropriately, safe; dose figures are quoted from published sources to explain why ionizing methods are unsuitable for monthly monitoring, not to discourage anyone from X-rays their dentist recommends. Diagnostic ultrasound is non-ionizing but has its own safety limits on acoustic output, which S-WAVE™ testing must meet.

Legal

Investor Notices

Effective October 31, 2026 · KronosMD, Inc.

No offer

This Site is not an offer to sell or a solicitation of an offer to buy securities. KronosMD, Inc. is offering Series CF Preferred Stock under Section 4(a)(6) of the Securities Act and Regulation Crowdfunding solely through PicMii Crowdfunding, LLC dba Highlander Crowdfunding, a funding portal registered with the SEC and FINRA. The offering is made only by means of the Form C, including its risk factors and financial statements, available on the portal and on the SEC’s EDGAR system.

Communications policy (Rule 204)

Outside the funding portal, KronosMD limits offering communications to the terms of the offering and factual business information, as Regulation Crowdfunding permits, and directs investors to the portal for the full offering. We answer investor questions about the offering in writing in the portal’s public Q&A so every investor sees the same answer. Our officers, directors and anyone compensated to promote the offering will identify themselves as such in any portal communication.

Risk

Investing in early-stage companies is speculative and involves a high degree of risk, including the loss of your entire investment. There is no public market for our securities and resale is restricted for one year, with limited exceptions. S-WAVE™ may never receive FDA authorization or reach the market. Please read the risk factors in the Form C and on our Investors page before investing.

Investment limits and cancellation

Non-accredited investors are limited in how much they may invest across all Regulation Crowdfunding offerings in a 12-month period, based on income and net worth. You may cancel an investment commitment for any reason up to 48 hours before the offering deadline stated on the portal. If we reach the target amount early and set a new deadline, the portal will notify you and you may cancel until 48 hours before the new deadline. Funds are held in escrow by the portal’s escrow agent until the offering closes.

Bonus shares and perks

Any time- or amount-based bonus shares described on the portal are part of the offering terms in the Form C. They are not an indication of value, and the portal page governs if this Site and the portal differ.

Ongoing reporting

After the offering closes we will file an annual report on Form C-AR and post it on the Investors page, and will file a Form C-U progress update and any Form C/A amendments as required. Reporting obligations may end in the circumstances permitted by Regulation Crowdfunding.

Forward-looking statements

Statements about plans, product capabilities, regulatory pathways, timing, markets, milestones and illustrative figures are forward-looking and based on assumptions that may prove wrong. Actual results may differ materially. KronosMD undertakes no obligation to update them.

No investment advice; no testimonials

Nothing on this Site is investment, legal or tax advice. Consult your own advisers. The Site contains no investor testimonials or endorsements; any quoted shareholder figures are counts from our register, not recommendations.

Prior shareholders

The approximately 350 existing shareholders described on the Site acquired their shares in prior transactions on different terms. Nothing about those holdings is a prediction of returns.

Legal

Website Usage Policy

Effective October 31, 2026 · KronosMD, Inc.

This policy sets out how the Site and its content may and may not be used. It supplements the Terms of Use.

Permitted uses

• Reading, printing and sharing links to pages for personal, educational or journalistic purposes.
• Quoting short excerpts with attribution to KronosMD and a link to the page.
• Citing the peer-reviewed studies we list, by their original citation.

Prohibited uses

• Reproducing illustrations, data visualizations, product renderings or bench images without written permission, or presenting them as clinical images.
• Using any content to promote the offering, including on social media, in a way that adds claims the Site does not make; the Regulation Crowdfunding communications rules apply to anyone compensated by KronosMD.
• Stating or implying that S-WAVE™ is FDA cleared, available for sale, or proven in people.
• Automated scraping, data mining or bulk downloading; security testing without authorization; or any attempt to bypass access controls.
• Submitting health information, patient images or records through any contact form or email; we will delete them.
• Posting or sending unlawful, defamatory, infringing or harassing material.

User submissions

Anything you send us through the Site (ideas, feedback, questions) is non-confidential unless we agree otherwise in writing. You grant KronosMD a perpetual, royalty-free licence to use feedback for any purpose. Do not send confidential inventions; use a signed agreement instead.

Copyright complaints (DMCA)

If you believe content on the Site infringes your copyright, send a notice meeting 17 U.S.C. §512(c)(3) to our designated agent at [email protected] with “DMCA” in the subject line, or by mail to KronosMD, Inc., 1000 Newbury Rd., Suite 290A, Thousand Oaks, CA 91320.

Enforcement

We may remove content, block access or pursue legal remedies for violations of this policy.

Legal

Trademarks, Patents and Sources

Effective October 31, 2026 · KronosMD, Inc.

Trademarks

S-WAVE™ and the KronosMD name and logo are trademarks of KronosMD, Inc. Align, Invisalign, iTero, DentalMonitoring, Butterfly, Colgate-Palmolive, Carestream, Konica Minolta and other names appearing on the Site are trademarks of their respective owners, used only to identify those companies and products. Their appearance does not imply any affiliation, endorsement or licence.

Patents

S-WAVE™ technology is covered by U.S. Patent No. 10,799,210. Additional applications are planned. A forward citation of our patent by another applicant does not imply licensing, infringement or endorsement. Other parties hold patents in related fields; see the Patents page and the Form C for the related risk disclosure.

Sources

Market, industry and dose figures come from third-party sources believed reliable and from Company estimates; they have not been independently verified. Sources include: CDC BRFSS 2024; NIDCR/CDC; CDC/NCHS Data Brief 531 (2025); Health Physics Society (Ludlow et al. 2008) and NCRP dose summaries; Humana Dental Procedure Pricing Tool (May 2026); Align Technology Q4/FY2025 results (Feb. 2026) and 2025 Form 10-K; DentalMonitoring announcements (Feb. 2026); USPTO records for US 10,799,210 and US 6,589,054; FDA AI-enabled medical device list as reported by industry trackers through Dec. 2025; Gadicherla et al. 2021; Patil et al. 2021; the dental ultrasound literature cited on the Research page; Kingscrowd and Crowdfund Capital Advisors reports; KronosMD Form C and shareholder register.